BioMerieux Other Non-Current Liabilities 2017-2024 | BMXMF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BioMerieux other non-current liabilities for 2024 were $0.053B, a 7.71% decline from 2023.
BioMerieux other non-current liabilities for 2023 were $0.058B, a 33.22% increase from 2022.
BioMerieux other non-current liabilities for 2022 were $0.043B, a 41.44% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

BioMerieux other non-current liabilities for 2024 were $0.053B, a 7.71% decline from 2023.
BioMerieux other non-current liabilities for 2023 were $0.058B, a 33.22% increase from 2022.
BioMerieux other non-current liabilities for 2022 were $0.043B, a 41.44% decline from 2021.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$139.4B
CVS Health (CVS)	$80.1B
Elevance Health (ELV)	$68.3B
Cencora (COR)	$57.1B
DiDi Global (DIDIY)	$27.2B
Labcorp Holdings (LH)	$20.7B
Natera (NTRA)	$19.6B
EUROFINS SCIENT (ERFSF)	$13.9B
CochLear (CHEOY)	$13.1B
Solventum (SOLV)	$12.8B
ICON (ICLR)	$11.9B
Revvity (RVTY)	$11.3B
Viatris (VTRS)	$10.9B
Medpace Holdings (MEDP)	$9.2B
Avantor (AVTR)	$9.1B
Sonic Healthcare (SKHHY)	$8.8B
HealthEquity (HQY)	$8.7B
Caris Life Sciences,�Inc (CAI)	$8B
Charles River Laboratories (CRL)	$7.7B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.2B
Surgery Partners (SGRY)	$2.9B
Alignment Healthcare (ALHC)	$2.6B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
GeneDx Holdings (WGS)	$2.3B
Progyny (PGNY)	$2B
PACS (PACS)	$1.9B